Become a Certified Microbiome Analyst

Module 14 – In Depth Reviews of Different Microbiome Testing Options and Interpretation Walk Through.

This week we’ll delve into the testing approaches (and their technologies) that are available for clinicians to assess the health of the microbiome. We’ll look at the strengths and weaknesses of the different microbiota assessment techniques and the labs offering them. We’ll cover tests using culturing, 16s rRNA, PCR, and shotgun metagenomic technology. We’ll specifically detail the tests Dr Hawrelak uses in his clinical practice and walk through how he extracts and interprets the data from these different tests for his patients.

Module 17 – Endotoxemia – Addressing a Key Driver of Chronic Disease

Endotoxemia is a key driver of chronic disease that is seldom on the radar of healthcare practitioners. Research conducted over the past 15 years has begun to shed considerable light on the disease-causing capacity of bacterial endotoxins. In module 17, we’ll dive into endotoxemia, describing what endotoxins are, detail their origins in the GIT and discuss how they are key drivers in many different chronic diseases common in Western nations, including metabolic diseases, cardiovascular conditions, and neurological disorders. We’ll cover current ways of assessing our patients for endotoxemia and explore future testing possibilities. Lastly, we’ll detail the tools that practitioners can use to address endotoxemia, including dietary recommendations, specific probiotics, prebiotics, and herbal medicines that can effectively address their production and absorption in the GIT and enhance their clearance.

Module 19 – The Role of the Microbiota in Cognitive Decline & Alzheimer’s Disease

The important role of the microbiome-gut-brain axis in the pathogenesis of cognitive decline and Alzheimer’s disease is becoming increasingly clear. Module 19 delves into the drivers of the dysfunction in the microbiome-gut-brain axis that contributes to cognitive decline and covers how we can use microbiota optimisation as an additional strategy to both prevent and treat cognitive decline and Alzheimer’s disease.

Module 21 – How to Harness the Microbiome for Enhancing Longevity and Healthy Aging
Module 22 – Metabolic Disease and the Microbiome

Aging and chronic disease are often linked. Yet, many age without developing them. Chronological age isn’t always biological age. In Module 21, we’ll explore the microbiota’s role in aging, its typical changes in Western aging, and strategies for preserving a youthful microbiota to delay biological aging.

Metabolic syndrome and type 2 diabetes rates have risen sharply. A large portion of the population now has these conditions. Recent research suggests a strong link between them and gut microbiota dysbiosis. In Module 22, we’ll review this research and discuss treatment approaches to improve metabolic disease outcomes.

Module 24 – Optimising the Microbiota to Enhance Cancer Outcomes
Module 25 – Common Microbiota Patterns and How to Address Them – Proteobacteria Blooms, Bacteroides Overgrowth, Prevotella Overgrowth

Over the past few years, a growing body of evidence is suggesting that treatment outcomes in cancer patients are influenced by the composition of their GI ecosystem. With some ecosystem compositions associated with poorer outcomes and other patterns associated with enhanced survival and better treatment tolerability. In Module 24, we’ll highlight the recent research findings in this area with a view of enabling clinicians to optimise their patients’ ecosystems before (and during) conventional cancer treatment as a complementary approach to improve treatment outcomes. Our final lesson, Module 25, will cover some common dysbiotic patterns and using cases from Dr Hawrelak’s practice, show how they can be successfully addressed.